We are a team of seventeen scientists and engineers (molecular biology, surface chemistry, microfluidics, and chip design) bringing together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data. We have been working together since 2016 on the development of this ground-breaking science
We are creating an infrastructure of technology and data to manage contagious viral diseases, important for the future of decentralised connected healthcare and wellbeing.
Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.